MedTrace Logo

Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.

NCT00262561 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 263

Last updated 2014-01-28

No results posted yet for this study

Summary

263 patients with peripheral atherosclerosis were examined to evaluate the activity of the platelets during the standard treatment, including aspirin. A subgroup of 43 received 600 mg of clopidogrel 2 h before platelet reactivity analysis.

The main hypothesis is that high platelet activity at the beginning of the study is associated with a higher risk of atherothrombosis. Follow up time is 5 years.

Conditions

  • Intermittent Claudication

Interventions

DRUG

Aspirin

The effect of Aspirin on platelet function was assessed.

Sponsors & Collaborators

  • Danish Heart Foundation

    collaborator OTHER

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Nils Johannesen, MD · Department of Vascular Surgery, Aalborg Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00262561 on ClinicalTrials.gov